<DOC>
	<DOCNO>NCT02922517</DOCNO>
	<brief_summary>Fibrosis , myocardial deformation biomarkers hypertrophic cardiomyopathy ( HCM )</brief_summary>
	<brief_title>Predictive Factors Consequences Myocardial Fibrosis Hypertrophic Cardiomyopathy</brief_title>
	<detailed_description>Hypertrophic cardiomyopathy ( HCM ) rare genetic disease ( 1 ) , whose phenotypic expression find less 1/1000 people , mainly link mutation protein sarcomere ( 14 gene 400 mutation identify nowadays ) . HCM occur 50 % case young adult age 30 year . Progress identification responsible mutation allow significant advance clinical management evaluation prognosis patient HCM . In fact , link genotype phenotype poor HCM , identification mutation approximately 60 % patient properly characterize disease evolution . It therefore necessary identify new marker well characterize HCM patient . Myocardial fibrosis could severity marker HCM consequence determinants little known unknown . The objective work identify determinant consequences myocardial fibrosis HCM , particularly relationship fibrosis leave ventricular dysfunction assess analysis myocardial deformation fibrosis heart failure . The study fibrosis , concern 30 70 % patient replace 1 70 % myocardial tissue , make possible vivo analysis delay enhancement gadolinium MRI . This work aim study relationship myocardial fibrosis , heart function assess myocardial deformation , heart failure , biological profile ( proteomics ) patient rest exertion . This study observational research . Indeed , examination do part usual care patient . Only additional tube blood collect initial biological assessment .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy , Hypertrophic</mesh_term>
	<criteria>Patients know HCM recently discover wall thickness great equal to15 mm without family background &gt; 13 mm HCM family context absence cause find capable produce degree hypertrophy HCM apparently link mutation protein sarcomere ( identify mutation absence cause hypertrophy find mutation search perform unsuccessful ) Control subject patient great equal 18 year without know cardiovascular disease may affect ability function , address achieve stress echocardiography assessment atypical symptom , low pretest probability coronary artery disease , accept blood sample exercise . They realize Holter ECG cardiac MRI part study . Refusal patient Age &lt; 16 year old Valvulopathy associate significant ( grade 3 4 regurgitation , severe stenosis ) mitral insufficiency Defibrillator , pacemaker , consindication intolerance achieve MRI Unable receive clear information ( patient 's intellectual default ) Under protective measure justice</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>biomarkers</keyword>
	<keyword>echocardiography</keyword>
	<keyword>MRI imaging</keyword>
	<keyword>nuclear medicine</keyword>
</DOC>